-
Mashup Score: 4Current Treatment Protocols for Ph+ ALL Treatment - 23 hour(s) ago
Josep Maria Ribera, MD, PhD, discusses the current standard treatment protocols for Philadelphia chromosome-positive acute lymphoblastic leukemia and the rationale behind them.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Optimizing Transplant Timing in Acute Lymphoblastic Leukemia - 2 month(s) ago
Partow Kebriaei, MD, discusses when the optimal time for transplant is in patients with acute lymphoblastic leukemia.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
WATCH: Partow Kebriaei, MD, discusses when the optimal time for transplant is in patients with acute lymphoblastic leukemia. #ALL #leusm | @MDAndersonNews https://t.co/ekawEhtjDH
-
-
Mashup Score: 0
Mark R. Litzow, MD, discusses the findings from the ECOG-ACRIN E1910 trial which evaluated blinatumomab added to chemotherapy vs chemotherapy alone in B-cell precursor acute lymphoblastic leukemia.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Mark R. Litzow, MD, discusses the findings from the ECOG-ACRIN E1910 trial which evaluated blinatumomab added to chemotherapy vs chemotherapy alone in B-cell precursor #ALL. #leusm | @MayoCancerCare @MayoClinic https://t.co/QzXxWmFwJf
-
-
Mashup Score: 0The Changing Landscape of Ph-Positive ALL - 2 month(s) ago
In an interview with Targeted Oncology, Josep Maria Ribera, MD, PhD, discussed the evolving treatment protocols for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Josep Maria Ribera, MD, PhD, discussed the evolving treatment protocols for Philadelphia chromosome-positive acute lymphoblastic leukemia. #ALL #leusm | @ICO_oncologia https://t.co/PdeCvGbovt
-
-
Mashup Score: 3Integrating Immunotherapy Into Frontline ALL Treatment - 4 month(s) ago
In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute lymphoblastic leukemia treatment.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute lymphoblastic leukemia treatment. #ALL #leusm | @MayoCancerCare @MayoClinic https://t.co/fHHaXJZTSV https://t.co/NFTl4KaCId
-
-
Mashup Score: 115Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia. - 4 month(s) ago
Although complete remission rates in adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have improved over the last two decades, it is sti
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
One of the best papers in the treatment of #ALL , in 2024 by @TalhaBadarMD , you can read this >>> Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia https://t.co/3Hvz8NanU4 #leusm https://t.co/Kxk8BBjuS8
-
-
Mashup Score: 9Behind Brexu-cel's Development in Relapsed/Refractory B-Cell ALL - 5 month(s) ago
In an interview with Targeted Oncology, Evandro D. Bezerra, MD, discusses brexucabtagene autoleucel for relapsed/refractory B-cell ALL.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
WATCH: Evandro D. Bezerra, MD, discusses brexucabtagene autoleucel for relapsed/refractory B-cell #ALL. #LEUSM | @E_D_Bezerra @OSUHematology @OSUCCC_James https://t.co/ioPKBTJ5gK
-
-
Mashup Score: 1Inotuzumab Ozogamicin Plus Blinatumomab ‘Highly Active’ in Older Patients with ALL | Blood Cancers Today - 6 month(s) ago
Inotuzumab ozogamicin induction followed by blinatumomab consolidation was studied in older patients with newly diagnosed Ph-negative CD22-positive B-lineage ALL.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
Blinatumomab was recently approved by the @US_FDA for B-cell #ALL, and coincidentally we published this article on blinatumomab combination therapy a year ago today! Check out the study led by Matthew Wieduwilt, MD, of @AtriumHealthWFB. #leusm ➡️ https://t.co/cvgujrJWtS https://t.co/a8dncGaPOf
-
-
Mashup Score: 138
In a pair of Special Reports, Gökbuget and colleagues present updated European Leukemia Net (ELN) consensus reports on (1) the diagnosis, prognostic factor
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Management of #ALL in adults: 2024 ELN recommendations from a European expert panel https://t.co/8rajb8llxe #leusm https://t.co/eCpGobVO3b
-
-
Mashup Score: 138
In a pair of Special Reports, Gökbuget and colleagues present updated European Leukemia Net (ELN) consensus reports on (1) the diagnosis, prognostic factor
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Management of #ALL in adults: 2024 ELN recommendations from a European expert panel https://t.co/8rajb8llxe #leusm https://t.co/eCpGobVO3b
-
Josep Maria Ribera, MD, PhD, discusses the current standard treatment protocols for Philadelphia chromosome-positive #ALL and the rationale behind them. #leusm | @ICO_oncologia https://t.co/MCp6V8YZpe